Atypical Exanthem as Cutaneous Manifestation Related to COVID-19 at a Primary Healthcare Facility

Prasetyadi Mawardi, Danu Yuliarta, Waode Nuraida

Abstract


Coronavirus disease (COVID-19) infection attacks the mucosal structures of the respiratory tract, especially the bronchial mucosa and immune cells. The skin changes and manifestations related to COVID-19 infection remain not clearly understood. Cutaneous manifestations related to COVID-19 had been reported. Our patient manifested atypical cutaneous exanthem on her legs, with no other abnormalities found. We used oral azithromycin 500 mg, dexamethasone 0.5 mg, vitamin C 100 mg, and paracetamol 500 mg, which are available at Badak Baru Primary Health Care. The exanthem has improved after 10 days of treatment.

Keywords


atypical cutaneous manifestation; covid-19; exanthem; primary health care

References


WHO. Coronavirus disease 2019 (COVID-19) situation report - 59. Accessed April 10, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200319-sitrep-59-covid-19.pdf

Zhu N, Zhang D, Wang W, et al. A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33.

Iancu GM, Solomon A, Birlutiu V. Viral exanthema as manifestation of SARS-CoV-2 infection: A case report. Medicine (Baltimore). 2020;99(35):e21810.

Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9.

Gisondi P, PIaserico S, Bordin C, et al. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. J Eur Acad Dermatol Venereol. 2020;34(11):2499-504.

Yao X, Li T, He Z, et al. Histopathological study of new Coronavirus pneumonia (COVID-19) in three patients. Chinese J Pathol. 2020;49.

Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-3.

Drago F, Rampini P, Rampini E, et al. Atypical exanthems: Morphology and laboratory investigations may lead to an aetiological diagnosis in about 70% of cases. Br J Dermatol. 2002;147(2):255-60.

Casas CG, Catal A, Hernández GC, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-7.

Garcia JJG. Differential diagnosis of viral Exanthemas. Open Vaccine J. 2010;3:65-8.

Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020;55(4):9-11.

Pradhan S, Madke B, Kabra P, et al. Anti-inflammatory and immunomodulatory effects of antibiotics and their use in dermatology. Indian J Dermatol. 2016;61(5):469-81.

Newton R. Molecular mechanism of glucocorticoid action : what is important?. Thorax. 2000;55:603-13.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.